Assessment of Drumstick Tree (M. deifera) Accessions for Genetic Diversity in the Southern guinea Region of Nigeria

An experiment was conducted to analyze the genetic diversity among 9 drumstick tree (Moringaoleifera) accessions in the Teaching and Research Farm of the University of Agriculture Makurdi. The experiment was laid out in a Randomized Complete Block Design (RCBD) replicated three times. Data were recorded on growth and yield characteristics before and after pruning. The result obtained showed that at 18 weeks after transplanting, accession UAM-NI had the tallest plants (3.63m) while UAM-BE had the shortest mean plant height (2.84m) under no pruning. Other parameters that showed significant differences were number of leaves per tree and stem diameter. Although accession UAM-OY recorded highest fresh (220.22g), dry (113.42g) and leaf powder (82.60g) weights, it was not significantly different from other accessions. However, at 18 weeks after pruning, there was a significant difference among the accessions with regard to leaf length. Although accession UAM-NA recorded highest fresh leaf weight (286.60g), dry leaf weight (90.67g) and leaf powder weight (85.60g), it was not statistically different from other accessions. For the pruned accessions, significant differences were recorded in leaf length, number of flowers/tree, days to podding and fifty percent podding, pod length, pod girth, pod weight, number of seeds/pod, number of seeds/tree and 100seed weight. The result also indicated that the pruned accessions recorded higher leaf yield than the unpruned. The result of the cluster analysis grouped the accessions into two clusters and an outlier both for the pruned and unpruned accessions irrespective of area of collection

State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS)

PCOS, a heterogeneous disorder characterized by cystic ovarian morphology, androgen excess, and/or irregular periods, emerges during or shortly after puberty. Peri- and post-pubertal obesity, insulin resistance and consequent hyperinsulinemia are highly prevalent co-morbidities of PCOS and promote an ongoing state of excess androgen. Given the relationship of insulin to androgen excess, reduction of insulin secretion and/or improvement of its action at target tissues offer the possibility of improving the physical stigmata of androgen excess by correction of the reproductive dysfunction and preventing metabolic derangements from becoming entrenched. While lifestyle changes that concentrate on behavioral, dietary and exercise regimens should be considered as first line therapy for weight reduction and normalization of insulin levels in adolescents with PCOS, several therapeutic options are available and in wide use, including oral contraceptives, metformin, thiazolidenediones and spironolactone. Overwhelmingly, the data on the safety and efficacy of these medications derive from the adult PCOS literature. Despite the paucity of randomized control trials to adequately evaluate these modalities in adolescents, their use, particularly that of metformin, has gained popularity in the pediatric endocrine community. In this article, we present an overview of the use of insulin sensitizing medications in PCOS and review both the adult and (where available) adolescent literature, focusing specifically on the use of metformin in both mono- and combination therapy